205 related articles for article (PubMed ID: 25869298)
1. Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice.
Edwards LJ; Mizui M; Kyttaris V
Clin Immunol; 2015 Jun; 158(2):221-30. PubMed ID: 25869298
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
3. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
Yao L; Chen HP; Ma Q
Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
[TBL] [Abstract][Full Text] [Related]
4. T cell-specific STAT3 deficiency abrogates lupus nephritis.
Yoshida N; He F; Kyttaris VC
Lupus; 2019 Oct; 28(12):1468-1472. PubMed ID: 31551033
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
Yang J; Li Q; Yang X; Li M
Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
[TBL] [Abstract][Full Text] [Related]
6. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
7. S3I-201 ameliorates tubulointerstitial lesion of the kidneys in MRL/lpr mice.
Du Y; Zhang W; Liu S; Feng X; Gao F; Liu Q
Biochem Biophys Res Commun; 2018 Sep; 503(1):177-180. PubMed ID: 29885836
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
Front Immunol; 2021; 12():584414. PubMed ID: 33717066
[TBL] [Abstract][Full Text] [Related]
9. [Expression of STAT3 and PIAS3 in renal tissues of MRL/lpr mice].
Yang H; Xu A; Lv J; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):821-5. PubMed ID: 22699062
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
Zhang Z; Liu D; Zhang X; Wang X
Inflammation; 2018 Oct; 41(5):1888-1899. PubMed ID: 29951872
[TBL] [Abstract][Full Text] [Related]
11. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
13. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
[TBL] [Abstract][Full Text] [Related]
14. Cryptotanshinone ameliorates the pathogenesis of systemic lupus erythematosus by blocking T cell proliferation.
Du Y; Du L; He Z; Zhou J; Wen C; Zhang Y
Int Immunopharmacol; 2019 Sep; 74():105677. PubMed ID: 31177018
[TBL] [Abstract][Full Text] [Related]
15. STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis.
Zhu J; Chen Y; Chen Y; Lv Y; Chen T
Ren Fail; 2024 Dec; 46(1):2358187. PubMed ID: 38803234
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
Pérez de Lema G; Lucio-Cazaña FJ; Molina A; Luckow B; Schmid H; de Wit C; Moreno-Manzano V; Banas B; Mampaso F; Schlöndorff D
Kidney Int; 2004 Sep; 66(3):1018-28. PubMed ID: 15327395
[TBL] [Abstract][Full Text] [Related]
17. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
[TBL] [Abstract][Full Text] [Related]
18. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M
Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801
[TBL] [Abstract][Full Text] [Related]
19. Glomerular cytokine expression in murine lupus nephritis.
Tshilela KA; Ikeuchi H; Matsumoto T; Kuroiwa T; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Hiromura K; Nojima Y
Clin Exp Nephrol; 2016 Feb; 20(1):23-9. PubMed ID: 25985839
[TBL] [Abstract][Full Text] [Related]
20. Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2-STAT3 pathway.
Jiang Y; Chen H; Lin J; Pan J; Shen Y; Li Q
Clin Exp Pharmacol Physiol; 2023 Dec; 50(12):936-943. PubMed ID: 37727880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
